Search Results - "Luan, Fu L."

New-Onset Diabetes Mellitus in Kidney Transplant Recipients Discharged on Steroid-Free Immunosuppression by LUAN, Fu L, STEFFICK, Diane E, OJO, Akinlolu O

Get full text

New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression by Luan, Fu L, Steffick, Diane E, Ojo, Akinlolu O

“…New-onset diabetes after transplant (NODAT) is a serious complication after kidney transplantation. We studied the relationship between steroid-free…”
Get full text

Chronic opioid analgesic usage post-kidney transplantation and clinical outcomes by Kulshrestha, Satyarth, Barrantes, Fidel, Samaniego, Milagros, Luan, Fu L.

“…Chronic opioid usage (COU) is common among patients with end‐stage renal disease (ESRD) qualified for kidney transplantation and associated with inferior…”
Get full text

Metabolic syndrome and new onset diabetes after transplantation in kidney transplant recipients by Luan, Fu L., Langewisch, Eric, Ojo, Akinlolu

“…Luan FL, Langewisch E, Ojo A. Metabolic syndrome and new onset diabetes after transplantation in kidney transplant recipients. 
Clin Transplant 2010: 24:…”
Get full text

Novel views on new-onset diabetes after transplantation: development, prevention and treatment by Hecking, Manfred, Werzowa, Johannes, Haidinger, Michael, Hörl, Walter H, Pascual, Julio, Budde, Klemens, Luan, Fu L, Ojo, Akinlolu, de Vries, Aiko P J, Porrini, Esteban, Pacini, Giovanni, Port, Friedrich K, Sharif, Adnan, Säemann, Marcus D

“…New-onset diabetes after transplantation (NODAT) is associated with increased risk of allograft failure, cardiovascular disease and mortality, and therefore,…”
Get full text

Alemtuzumab in Kidney-Transplant Recipients by Luan, Fu L

“…To the Editor: Hanaway et al. (May 19 issue) 1 report the 3-year results of a randomized clinical trial comparing alemtuzumab with conventional induction…”
Get full text

Universal Prophylaxis is Cost Effective in Cytomegalovirus Serology-Positive Kidney Transplant Patients by LUAN, Fu L, KOMMAREDDI, Mallika, OJO, Akinlolu O

“…The economic merit of universal prophylaxis and preemptive therapy in the management of cytomegalovirus (CMV) infection for serology positive (R+) kidney…”
Get full text

Comparison of the long-term outcomes of kidney transplantation: USA versus Spain by Ojo, Akinlolu O, Morales, José María, González-Molina, Miguel, Steffick, Diane E, Luan, Fu L, Merion, Robert M, Ojo, Tammy, Moreso, Francesc, Arias, Manuel, Campistol, Josep María, Hernandez, Domingo, Serón, Daniel

“…The long-term outcomes of kidney transplantation are suboptimal because many patients lose their allografts or experience premature death. Cross-country…”
Get full text

Six-Month Prophylaxis Is Cost Effective in Transplant Patients at High Risk for Cytomegalovirus Infection by LUAN, Fu L, STUCKEY, Linda J, PARK, Jeong M, KAUL, Daniel, CIBRIK, Diane, OJO, Akinlolu

“…The risk of late-onset cytomegalovirus (CMV) infection remains a concern in seronegative kidney and/or pancreas transplant recipients of seropositive organs…”
Get full text

Delayed graft function requiring more than one-time dialysis treatment is associated with inferior clinical outcomes by Jayaram, Deepa, Kommareddi, Mallika, Sung, Randall S., Luan, Fu L.

“…Delayed graft function (DGF) is a common complication of deceased donor kidney transplantation with negative impact on clinical outcomes. In a single‐center…”
Get full text

Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? by Luan, Fu L., Steffick, Diane E., Ojo, Akinlolu O.

“…Steroid-free immunosuppression in kidney transplantation has been gaining popularity over the past decade, as documented by a continuous and steady rise in the…”
Get full text

A history of chronic opioid usage prior to kidney transplantation may be associated with increased mortality risk by Barrantes, Fidel, Luan, Fu L, Kommareddi, Mallika, Alazem, Kareem, Yaqub, Tareq, Roth, Randy S, Sung, Randall S, Cibrik, Diane M, Song, Peter, Samaniego, Millie

“…Chronic opioid usage (COU) for analgesia is common among patients with end-stage renal disease. In order to test whether a prior history of COU negatively…”
Get more information

Metabolic syndrome, vitamin D deficiency and hypoadiponectinemia among nondiabetic patients early after kidney transplantation by Kulshrestha, Satyarth, Ojo, Akinlolu O, Luan, Fu L

“…Metabolic syndrome (MetS) is common among kidney transplant patients. We studied the relationship between MetS, vitamin D deficiency/insufficiency and…”
Get more information

Rapamycin blocks tumor progression: Unlinking immunosuppression from antitumor efficacy by LUAN, Fu L, HOJO, Minoru, MALUCCIO, Mary, YAMAJI, Kouzaburo, SUTHANTHIRAN, Manikkam

“…Malignancy is a dreaded complication of organ transplantation. Immunosuppressive drug therapy-induced impairment of the organ graft recipient's immune…”
Get full text

Transplantation in Diabetic Kidney Failure Patients: Modalities, Outcomes, and Clinical Management by Luan, Fu L., Samaniego, Millie

“…Diabetes mellitus (DM) is a common and devastating disease, affecting up to 19.3 million Americans. It is the leading cause of chronic kidney disease (CKD) and…”
Get full text

Early Pancreas Graft Failure Is Associated With Inferior Late Clinical Outcomes After Simultaneous Kidney-Pancreas Transplantation by NORMAN, Silas P, KOMMAREDDI, Mallika, OJO, Akinlolu O, LUAN, Fu L

“…Early pancreas graft failure after simultaneous pancreas and kidney (SPK) transplantation is common. We studied the impact of early pancreas graft failure on…”
Get full text

Abnormal glucose metabolism and metabolic syndrome in non-diabetic kidney transplant recipients early after transplantation by Luan, Fu L, Stuckey, Linda J, Ojo, Akinlolu O

“…Abnormal glucose metabolism (AGM) and metabolic syndrome (MS) are individually associated with a poor cardiovascular outcome in kidney transplant recipients…”
Get full text

Rapamycin is an effective inhibitor of human renal cancer metastasis by LUAN, Fu L, RUCHUANG DING, SHARMA, Vijay K, CHON, W. James, LAGMAN, Milagros, SUTHANTHIRAN, Manikkam

“…Rapamycin is an effective inhibitor of human renal cancer metastasis. Human renal cell cancer (RCC) is common and is 10 to 100 times more frequent in patients…”
Get full text

Management of Hypertension in Solid-Organ Transplantation by Park, Jeong M., Luan, Fu L.

“…Posttransplant hypertension is a major risk factor for cardiovascular disease and chronic renal allograft dysfunction. A significant number of transplant…”
Get full text

Impact of Immunosuppressive Regimen on Survival of Kidney Transplant Recipients With Hepatitis C by LUAN, Fu L, SCHAUBEL, Douglas E, HUI ZHANG, XIAOYU JIA, PELLETIER, Shown J, PORT, Friedrich K, MAGEE, John C, SUNG, Randall S

“…Hepatitis C virus (HCV) infection is common among end-stage renal disease patients receiving hemodialysis and a kidney transplant. HCV-positive kidney…”
Get full text